New Drugs and Targets for Asthma & COPD
Imperial College / National Heart & Lung Institute
Archivo
19.11.2008 - 21.11.2008 London
Contenido de curso
This course is focussed on the identification of new targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area. The course will be of particular relevance to those in the pharmaceutical industry, researchers in respiratory medicine, and specialised clinicians and health care professionals
This course is focussed on the identification of new targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area. The course will be of particular relevance to those in the pharmaceutical industry, researchers in respiratory medicine, and specialised clinicians and health care professionals
Observaciones
(£250 daily rate) Special rate for SpRs: £300
(£250 daily rate) Special rate for SpRs: £300
Idioma
Inglés
Inglés
Costos
GBP 650,00
GBP 650,00
Cantacto organizador
Dovehouse Street
SW3 6LY
United Kingdom
Dovehouse Street
SW3 6LY
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
